Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease.
Saved in:
| Title: | Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease. |
|---|---|
| Authors: | Qapaja T; Division of Hospital Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Abu-Rumaileh M; Department of Internal Medicine, University of Toledo, Toledo, OH, USA., Alsabbagh Alchirazi K; Department of Gastroenterology, Aurora Health Care, Milwaukee, WI, USA., Gharaibeh A; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA., Naser A; Department of Internal Medicine, Jacobi Medical Center, New York, NY, USA., Hamid O; Department of Gastroenterology, University of Texas Southwestern, Dallas, TX, USA., Alayan D; Department of Pulmonary and Critical Care, MetroHealth Medical Center, Cleveland, OH, USA., Regueiro M; Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA. |
| Source: | Inflammatory bowel diseases [Inflamm Bowel Dis] 2025 Jul 07; Vol. 31 (7), pp. 1910-1916. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1536-4844 |
|---|---|
| DOI: | 10.1093/ibd/izae267 |
